Myeloproliferative Disorders (MPD) Treatment Market Size

Myeloproliferative Disorders Treatment Market size was over USD 9.34 billion in 2023 and is projected to cross USD 14.42 billion by the end of 2036, witnessing more than 3.4% CAGR during the forecast period i.e., between 2024-2036. In the year 2024, the industry size of myeloproliferative disorders treatment is estimated at USD 9.59 billion.

The increasing investments in research and development activities along with rising incidences of myeloproliferative disorders is predicted to boost the market growth. Furthermore, the rising awareness for molecular abnormalities and cellular pathways associated with the MPN pathogenesis is expected to facilitate the development of clinical trials and novel drugs, which is estimated to boost the market growth. There is no known cure for this disorder, so the treatment is focused on treating the symptoms, which include weight loss, pale skin, blood clotting and excessive blood loss, splenomegaly, cachexia, and others. This raises the scope for R&D activities for developing novel drugs and treatment methods for this disorder, which is estimated to boost the market growth.